BE899059A - Derives de benzamide - Google Patents

Derives de benzamide

Info

Publication number
BE899059A
BE899059A BE0/212488A BE212488A BE899059A BE 899059 A BE899059 A BE 899059A BE 0/212488 A BE0/212488 A BE 0/212488A BE 212488 A BE212488 A BE 212488A BE 899059 A BE899059 A BE 899059A
Authority
BE
Belgium
Prior art keywords
compounds
dichloro
benzamide derivatives
new
methylenedioxy
Prior art date
Application number
BE0/212488A
Other languages
English (en)
French (fr)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE899059A publication Critical patent/BE899059A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/212488A 1983-03-03 1984-03-02 Derives de benzamide BE899059A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1150/83A CH653670A5 (de) 1983-03-03 1983-03-03 Benzamid-derivate.

Publications (1)

Publication Number Publication Date
BE899059A true BE899059A (fr) 1984-09-03

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212488A BE899059A (fr) 1983-03-03 1984-03-02 Derives de benzamide

Country Status (28)

Country Link
JP (1) JPS59167552A (da)
KR (1) KR910008202B1 (da)
AR (1) AR243155A1 (da)
AT (1) AT390948B (da)
AU (2) AU570431B2 (da)
BE (1) BE899059A (da)
CA (1) CA1252794A (da)
CH (1) CH653670A5 (da)
DE (1) DE3407654C2 (da)
DK (1) DK166382C (da)
ES (3) ES530230A0 (da)
FI (1) FI79297C (da)
FR (1) FR2541996B1 (da)
GB (1) GB2135998B (da)
GR (1) GR81866B (da)
HU (1) HU193556B (da)
IE (1) IE57004B1 (da)
IL (1) IL71078A (da)
IT (1) IT1173365B (da)
LU (1) LU85231A1 (da)
MC (1) MC1568A1 (da)
NL (1) NL8400459A (da)
NO (1) NO165999C (da)
NZ (1) NZ207272A (da)
PH (1) PH19623A (da)
PT (1) PT78187B (da)
SE (1) SE466447B (da)
ZA (1) ZA841394B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (da) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (de) * 1976-04-14 1977-11-03 Basf Ag Farbstoffe der perylentetracarbonsaeurediimidreihe
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
GB2135998B (en) 1986-09-24
SE8401190L (sv) 1984-09-04
AU570431B2 (en) 1988-03-17
DK166382B (da) 1993-05-10
ES8504680A1 (es) 1985-05-01
CH653670A5 (de) 1986-01-15
FI79297C (fi) 1989-12-11
ES530230A0 (es) 1985-05-01
AU609758B2 (en) 1991-05-09
JPS59167552A (ja) 1984-09-21
FI840734A (fi) 1984-09-04
IE840512L (en) 1984-09-03
NO165999C (no) 1991-05-15
GR81866B (da) 1984-12-12
FR2541996B1 (fr) 1987-12-11
PT78187B (en) 1986-08-05
ES8506601A1 (es) 1985-08-16
IT1173365B (it) 1987-06-24
HU193556B (en) 1987-10-28
DK147584D0 (da) 1984-02-29
FI79297B (fi) 1989-08-31
NO840797L (no) 1984-09-04
PH19623A (da) 1986-06-04
SE466447B (sv) 1992-02-17
NO165999B (no) 1991-02-04
AT390948B (de) 1990-07-25
AU2506684A (en) 1984-09-06
ATA72484A (de) 1990-01-15
ES8506600A1 (es) 1985-08-16
CA1252794A (en) 1989-04-18
FI840734A0 (fi) 1984-02-22
ES537046A0 (es) 1985-08-16
IL71078A (en) 1987-12-31
DE3407654C2 (de) 1994-04-07
DE3407654A1 (de) 1984-09-06
IE57004B1 (en) 1992-03-11
NZ207272A (en) 1987-07-31
NL8400459A (nl) 1984-10-01
ZA841394B (en) 1985-06-26
MC1568A1 (fr) 1985-02-04
ES537045A0 (es) 1985-08-16
DK166382C (da) 1993-09-27
LU85231A1 (de) 1985-09-12
GB8405486D0 (en) 1984-04-04
IT8419778A0 (it) 1984-02-23
GB2135998A (en) 1984-09-12
PT78187A (en) 1984-04-01
KR910008202B1 (ko) 1991-10-11
IL71078A0 (en) 1984-05-31
AU8307987A (en) 1988-06-16
SE8401190D0 (sv) 1984-03-02
AR243155A1 (es) 1993-07-30
KR840009077A (ko) 1984-12-24
JPH0430389B2 (da) 1992-05-21
FR2541996A1 (fr) 1984-09-07
DK147584A (da) 1984-09-04

Similar Documents

Publication Publication Date Title
BE903334A (fr) Nouveaux derives naphtaleniques a action retinoique, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
GEP19960313B (en) Method for Production of Pyridin Derivatives
ATE36149T1 (de) Antikonvulsive sulfamatderivate.
Franzen et al. Biologically Active Amines Found in Man: Their Biochemistry, Pharmacology, and Pathophysiological Importance
MA27559A1 (fr) Nouveaux derives de fluorglycoside aromatiques, produits pharmaceutiques contenant ces composes et leur utilisation
CA2164638A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
BE903110A (fr) Derives d'ethylenediaminemonoamide
AU4546685A (en) Pyrazole analogs of mevalonolactone and derivatives thereof, process for their production and their use
JPS57142962A (en) Cyclodextrin clathrate compound of sulfur-containing compound
BE899059A (fr) Derives de benzamide
JPS54160740A (en) Anti-fibrotic agent
KR900001683A (ko) 피페리딘 유도체
PT82032B (pt) Processo para a preparacao de derivados de aminoacidos com accao anticonvulsiva e de composicoes farmaceuticas que os contem
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
DK562488D0 (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
BR9911611A (pt) Fenóis rádio-iodados para braquiterapia
IE42218L (en) Pyrazinoisoquinoline derivatives
PT77666A (fr) Procede de preparation de nouveaux derives de la nitrosouree
CA2282666A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ES8706612A1 (es) Procedimiento para preparar derivados de butiramida
US4415591A (en) Use of aminoalkyl phenyl sulfide derivatives for the treatment of hypertension
BE899465A (fr) Composes d'ammonium quaternaire bactericides.
KR890000406A (ko) 신나모일아미드 유도체, 그들의 제조방법, 그들을 함유하는 제약학적 조성물 및 그들의 사용
US4579870A (en) Aminoalkyl phenyl selenides for the treatment of hypertension and nervous system dysfunctions
US4205081A (en) Composition and method for preventing or treating swine dysentery

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE A.G.

Effective date: 19950331